The Recombinant DNA Technology Market size is expected to be worth around USD 1288.5 Bn by 2032 from USD 786.7 Bn in 2023, growing at a CAGR of 5.8% As scientific and technological advancements ...

Astrid Österreicher, Testbiotech’s policy advisor in Brussels, who helped to organise the joint letter, said, “In regard to future applications of NGTs, we currently only see the tip of the iceberg ...

Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.

One example of public debate over the use of ... for Economic Cooperation and Development (OECD), called "Recombinant DNA Safety Considerations," became the first intergovernmental document ...

What will be the significance of this month’s 50th anniversary meeting at the famed Pacific Grove conference centre in ...

Introduction Definition of Peptides Peptides are short chains of amino acids linked by peptide bonds, typically consisting of 2 to ...

The global prothrombin complex concentrates market is on a strong upward trajectory, with projections indicating substantial growth in the coming decade. According to a recent report by Future Market ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Agriculture biotech market was valued at $93.10 billion in 2021, and is estimated to reach $214.6 billion by 2031, growing at a CAGR of 8.8% from 202 ...

With Africa’s significant share of the world’s arable land and rich biodiversity, the foundation for a bioeconomy is strong. Unlocking its full potential can fuel economic growth.

Gov. Evers and Attorney General Kaul and 21 other states today sued the Trump Administration, the Department of Health and Human Services, and the National Institutes of Health (NIH) for unlawfully ...

A lot of people are staunchly pro-vaccines, some are militant anti-vaxxers and much of the population is wondering what all the fuss is about. If you already have a firm viewpoint on the question of ...